Ngā hua rapu - Haeun Hwangbo

  • E whakaatu ana i te 1 - 3 hua o te 3
Whakamahine hua
  1. 1
    Predictable Clinical Benefits without Evidence of Synergy in Trials of Combination Therapies with Immune-Checkpoint Inhibitors

    Predictable Clinical Benefits without Evidence of Synergy in Trials of Combination Therapies with Immune-Checkpoint Inhibitors mā Adam C. Palmer, Benjamin Izar, Haeun Hwangbo, Peter K. Sorger

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Additivity predicts the efficacy of most approved combination therapies for advanced cancer

    Additivity predicts the efficacy of most approved combination therapies for advanced cancer mā Haeun Hwangbo, Sarah C. Patterson, Andy Dai, Deborah Plana, Adam C. Palmer

    I whakaputaina 2023
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    An RNA damage response network mediates the lethality of 5-FU in colorectal cancer

    An RNA damage response network mediates the lethality of 5-FU in colorectal cancer mā Jung-Kuei Chen, Karl A. Merrick, Yi Wen Kong, Anita Izrael-Tomasevic, George Eng, Erika D. Handly, Jesse C. Patterson, Ian G. Cannell, Lucía Suárez-López, Aaron M. Hosios, Anh Dinh, Donald S. Kirkpatrick, Kebing Yu, Christopher M. Rose, Jonathan M. Hernandez, Haeun Hwangbo, Adam C. Palmer, Matthew G. Vander Heiden, Ömer Yılmaz, Michael B. Yaffe

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: